Samsung Biologics inks $879 million deal with Pfizer to make drugs
HQ Team July 4, 2023: Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, has inked two deals worth $897 million
HQ Team July 4, 2023: Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, has inked two deals worth $897 million
HQ Team July 3, 2023: Swiss drugmaker Novartis is divesting its ophthalmology assets including Xiidra, an anti-inflammatory eye drop to Bausch + Lomb,
HQ Team July 2, 2023: Biological or chemical threats may be lurking in the universe’s chemical world, or cures for disease and tackling
HQ Team July 1, 2023: Airseas, a French company that makes automated kites to channel wind power to tow cargo ships, plans to
Researchers at the University of Cambridge have moved away from cells of zebrafish and mice to create a “human embryo-like model” from human
HQ Team June 30, 2023: Artificial sweetener, sucralose, is “genotoxic” as it breaks up the DNA and causes damage to the gut lining
HQ Team June 30, 2023: Two philanthropic health majors, Wellcome and the Bill & Melinda Gates Foundation, have come together to invest around
HQ Team June 29, 2023: Recent research has shed new light on the connection between autism spectrum disorder (ASD) and the body’s ‘second
HQ Team June 29, 2023: Abandoned industrial sites with polluting material buried in and around the sites are difficult to clean up and